FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197724043> ?p ?o ?g. }

• W3197724043 endingPage "6707" @default.
• W3197724043 startingPage "6695" @default.
• W3197724043 abstract ": Lung transplant is a potential life-saving procedure for chronic lung diseases. Lung transplant recipients (LTRs) are at the greatest risk for invasive fungal infections (IFIs) among solid organ transplant (SOT) recipients because the allograft is directly exposed to fungi in the environment, airway and lung host defenses are impaired, and immunosuppressive regimens are particularly intense. IFIs occur within a year of transplant in 3–19% of LTRs, and they are associated with high mortality, prolonged hospital stays, and excess healthcare costs. The most common causes of post-LT IFIs are Aspergillus and Candida spp.; less common pathogens are Mucorales, other non-Aspergillus moulds, Cryptococcus neoformans, Pneumocystis jirovecii, and endemic mycoses. The majority of IFIs occur in the first year following transplant, although later onset is observed with prolonged antifungal prophylaxis. The most common manifestations of invasive mould infections (IMIs) include tracheobronchial (particularly at anastomotic sites), pulmonary and disseminated infections. The mortality rate of tracheobronchitis is typically low, but local complications such as bronchomalacia, stenosis and dehiscence may occur. Mortality rates associated with lung and disseminated infections can exceed 40% and 80%, respectively. IMI risk factors include mould colonization, single lung transplant and augmented immunosuppression. Candidiasis is less common than mould infections, and manifests as bloodstream or other non-pulmonary invasive candidiasis; tracheobronchial infections are encountered uncommonly. Risk factors for and outcomes of candidiasis are similar to those of non lung transplant recipients. There is evidence that IFIs and fungal colonization are risk factors for allograft failure due to chronic rejection. Mould-active azoles are frontline agents for treatment of IMIs, with local debridement as needed for tracheobronchial disease. Echinocandins and azoles are treatments for invasive candidiasis, in keeping with guidelines in other patient populations. Antifungal prophylaxis is commonly administered, but benefits and optimal regimens are not defined. Universal mould-active azole prophylaxis is used most often. Other approaches include targeted prophylaxis of high-risk LTRs or pre-emptive therapy based on culture or galactomannan (GM) (or other biomarker) results. Prophylaxis trials are needed, but difficult to perform due to heterogeneity in local epidemiology of IFIs and standard LT practices. The key to devising rational strategies for preventing IFIs is to understand local epidemiology in context of institutional clinical practices." @default.
• W3197724043 created "2021-09-13" @default.
• W3197724043 creator A5024677215 @default.
• W3197724043 creator A5065210908 @default.
• W3197724043 creator A5074182672 @default.
• W3197724043 date "2021-11-01" @default.
• W3197724043 modified "2023-09-24" @default.
• W3197724043 title "Fungal infections in lung transplantation" @default.
• W3197724043 cites W1603031115 @default.
• W3197724043 cites W1804118339 @default.
• W3197724043 cites W1940929438 @default.
• W3197724043 cites W1954254929 @default.
• W3197724043 cites W1966092471 @default.
• W3197724043 cites W1980359814 @default.
• W3197724043 cites W1998653894 @default.
• W3197724043 cites W2000351135 @default.
• W3197724043 cites W2018482202 @default.
• W3197724043 cites W2026927296 @default.
• W3197724043 cites W2027014835 @default.
• W3197724043 cites W2032765691 @default.
• W3197724043 cites W2049972959 @default.
• W3197724043 cites W2057220915 @default.
• W3197724043 cites W2059411228 @default.
• W3197724043 cites W2063170364 @default.
• W3197724043 cites W2065952164 @default.
• W3197724043 cites W2066460729 @default.
• W3197724043 cites W2066513461 @default.
• W3197724043 cites W2087291538 @default.
• W3197724043 cites W2092081063 @default.
• W3197724043 cites W2092681530 @default.
• W3197724043 cites W2096783798 @default.
• W3197724043 cites W2098807635 @default.
• W3197724043 cites W2105860549 @default.
• W3197724043 cites W2105904660 @default.
• W3197724043 cites W2112585732 @default.
• W3197724043 cites W2117868592 @default.
• W3197724043 cites W2119464747 @default.
• W3197724043 cites W2138426885 @default.
• W3197724043 cites W2144677985 @default.
• W3197724043 cites W2146315321 @default.
• W3197724043 cites W2161319077 @default.
• W3197724043 cites W2162061307 @default.
• W3197724043 cites W2208771901 @default.
• W3197724043 cites W2216117396 @default.
• W3197724043 cites W2340719445 @default.
• W3197724043 cites W2395064943 @default.
• W3197724043 cites W2417113879 @default.
• W3197724043 cites W2470291098 @default.
• W3197724043 cites W2522719223 @default.
• W3197724043 cites W2529616866 @default.
• W3197724043 cites W2603871746 @default.
• W3197724043 cites W2789788058 @default.
• W3197724043 cites W2917768372 @default.
• W3197724043 cites W2951349293 @default.
• W3197724043 cites W3026072426 @default.
• W3197724043 cites W3031421306 @default.
• W3197724043 cites W3088027053 @default.
• W3197724043 doi "https://doi.org/10.21037/jtd-2021-26" @default.
• W3197724043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34992845" @default.
• W3197724043 hasPublicationYear "2021" @default.
• W3197724043 type Work @default.
• W3197724043 sameAs 3197724043 @default.
• W3197724043 citedByCount "9" @default.
• W3197724043 countsByYear W31977240432022 @default.
• W3197724043 countsByYear W31977240432023 @default.
• W3197724043 crossrefType "journal-article" @default.
• W3197724043 hasAuthorship W3197724043A5024677215 @default.
• W3197724043 hasAuthorship W3197724043A5065210908 @default.
• W3197724043 hasAuthorship W3197724043A5074182672 @default.
• W3197724043 hasBestOaLocation W31977240431 @default.
• W3197724043 hasConcept C126322002 @default.
• W3197724043 hasConcept C141071460 @default.
• W3197724043 hasConcept C177713679 @default.
• W3197724043 hasConcept C203014093 @default.
• W3197724043 hasConcept C2777292849 @default.
• W3197724043 hasConcept C2777714996 @default.
• W3197724043 hasConcept C2780252810 @default.
• W3197724043 hasConcept C2781448352 @default.
• W3197724043 hasConcept C71924100 @default.
• W3197724043 hasConceptScore W3197724043C126322002 @default.
• W3197724043 hasConceptScore W3197724043C141071460 @default.
• W3197724043 hasConceptScore W3197724043C177713679 @default.
• W3197724043 hasConceptScore W3197724043C203014093 @default.
• W3197724043 hasConceptScore W3197724043C2777292849 @default.
• W3197724043 hasConceptScore W3197724043C2777714996 @default.
• W3197724043 hasConceptScore W3197724043C2780252810 @default.
• W3197724043 hasConceptScore W3197724043C2781448352 @default.
• W3197724043 hasConceptScore W3197724043C71924100 @default.
• W3197724043 hasIssue "11" @default.
• W3197724043 hasLocation W31977240431 @default.
• W3197724043 hasLocation W31977240432 @default.
• W3197724043 hasLocation W31977240433 @default.
• W3197724043 hasOpenAccess W3197724043 @default.
• W3197724043 hasPrimaryLocation W31977240431 @default.
• W3197724043 hasRelatedWork W1965567535 @default.
• W3197724043 hasRelatedWork W1988898636 @default.
• W3197724043 hasRelatedWork W1998447595 @default.
• W3197724043 hasRelatedWork W2033093608 @default.

• next